FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 78 filers reported holding FUSION PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $10,831 | -62.5% | 508 | -83.1% | 0.00% | – |
| Q4 2023 | $28,907 | +7907.5% | 3,008 | +2064.0% | 0.00% | – |
| Q3 2023 | $361 | -95.5% | 139 | -95.7% | 0.00% | – |
| Q2 2022 | $8,000 | +60.0% | 3,259 | +180.9% | 0.00% | – |
| Q4 2021 | $5,000 | -76.2% | 1,160 | -56.3% | 0.00% | -100.0% |
| Q3 2021 | $21,000 | -12.5% | 2,654 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | +41.2% | 3,015 | +93.5% | 0.00% | – |
| Q1 2021 | $17,000 | – | 1,558 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,502,425 | $39,994,000 | 10.54% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,670,516 | $44,120,000 | 8.88% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,551,794 | $30,673,000 | 0.55% |
| Orbimed Advisors | 3,224,770 | $38,762,000 | 0.49% |
| Perceptive Advisors | 2,235,983 | $26,877,000 | 0.39% |
| CLOUGH CAPITAL PARTNERS L P | 402,800 | $4,842,000 | 0.35% |
| Rock Springs Capital Management LP | 947,541 | $11,389,000 | 0.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 972,046 | $11,684,000 | 0.28% |
| CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 | $37,466,000 | 0.07% |
| Woodline Partners LP | 76,093 | $915,000 | 0.03% |